Posted Jul. 11, 2012 at 7:14 a.m.

Premium Lock GSK's experimental AIDS drug beats top seller in study

Published: 2012-07-11 07:14:49
Updated: 2012-07-11 07:14:49

HIV AIDS research HIV AIDS research

An experimental treatment for HIV developed by GlaxoSmithKline, Pfizer Inc. and Shionogi & Co. reduced the virus in more people than Gilead Sciences' Atripla, the world's best-selling AIDS medicine....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll